Abstract
Comparative genomic hybridization was applied to map DNA gains and losses in 39 invasive ductal breast carcinomas. Frequent abnormalities included gains on chromosomal regions 1q, 8q, 11q12-13, 16p, 19, 20q and X as well as frequent losses on 1p, 5q, 6q, 9p, 11q, 13q and 16q. Furthermore, frequent losses on 4q (20 cases) and 21q (14 cases) were found for the first time in this tumour type. High copy number amplifications were observed at 8q12-24, 11q11-13 and 20q13-ter. Highly differentiated tumours were associated with gains on 1q and 11q12-13 along with losses on 1p21-22, 4q, 13q, 11q21-ter. Undifferentiated breast carcinomas were characterized by additional DNA imbalances, i.e. deletions of 5q13-23, all of chromosome 9, the centromeric part of chromosome 13 including band 13q14 and the overrepresentation of chromosome X. We speculate that these changes are associated with tumour progression of invasive ductal breast cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schwendel, A., Richard, F., Langreck, H. et al. Chromosome alterations in breast carcinomas: frequent involvement of DNA losses including chromosomes 4q and 21q. Br J Cancer 78, 806–811 (1998). https://doi.org/10.1038/bjc.1998.583
Issue Date:
DOI: https://doi.org/10.1038/bjc.1998.583
This article is cited by
-
Gene expression meta-analysis in diffuse low-grade glioma and the corresponding histological subtypes
Scientific Reports (2017)
-
DNA methylation and carcinogenesis of PRDM5 in cervical cancer
Journal of Cancer Research and Clinical Oncology (2010)
-
PRDM5 is silenced in human cancers and has growth suppressive activities
Oncogene (2004)
-
High serum endostatin levels in Down syndrome: implications for improved treatment and prevention of solid tumours
European Journal of Human Genetics (2001)
-
The mammary myoepithelial cell - Cinderella or ugly sister?
Breast Cancer Research (2000)